PlainBillCongress, translated.Legislation. Context. Public interest.Veto message received in Senate. Ordered held at the desk.
Congressional Research Service
Version 81 · Passed House without amendment · Jun 7, 2007
(This measure has not been amended since it was introduced. The expanded summary of the Senate passed version is repeated here.)
Stem Cell Research Enhancement Act of 2007 - (Sec. 2) Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements.
Directs the Secretary to: (1) issue final guidelines to carry out this Act within 60 days; and (2) submit annual reports on activities and research conducted under this Act.
Showing the opening paragraphs of the official summary.
(Sec. 3) Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.
Sets forth reporting requirements.
Authorizes appropriations.
People & committees
Sen. Reid, Harry [D-NV] · D–NV
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Veto message received in Senate. Ordered held at the desk.
Vetoed by President. (text of veto message: CR S8060-8061)
Vetoed by President.(text of veto message: CR S8060-8061)
Presented to President.
Presented to President.
Cleared for White House.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by the Yeas and Nays: 247 - 176 (Roll no. 443). (text: CR H6125)
House roll call 443 · Individual votesPassed/agreed to in House: On passage Passed by the Yeas and Nays: 247 - 176 (Roll no. 443).(text: CR H6125)
House roll call 443 · Individual votesOn motion to commit with instructions Failed by the Yeas and Nays: 180 - 242 (Roll no. 442).
House roll call 442 · Individual votesThe previous question on the motion to commit with instructions was ordered without objection. (consideration: CR H6142-6143; text: H6141)
DEBATE - The House proceeded with 10 minutes of debate on the Gingrey motion to commit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment in the nature of a substitute inserting a complete new text entitled "Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007."
Mr. Gingrey moved to commit with instructions to Energy and Commerce. (consideration: CR H6141-6142)
The previous question was ordered pursuant to the rule. (consideration: CR H6141)
DEBATE - The House proceeded with one hour of debate on S. 5.
Rule provides for consideration of S. 5 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions. Measure will be considered read. Bill is closed to amendments. All points of order against the bill and against its consideration are waived except those arising under clause 10 of rule XXI. A motion to commit is in order.
Considered under the provisions of rule H. Res. 464. (consideration: CR H6125-6143)
Rule H. Res. 464 passed House.
Rules Committee Resolution H. Res. 464 Reported to House. Rule provides for consideration of S. 5 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions. Measure will be considered read. Bill is closed to amendments. All points of order against the bill and against its consideration are waived except those arising under clause 10 of rule XXI. A motion to commit is in order.
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 63 - 34. Record Vote Number: 127. (text as passed Senate: CR S4389-4390)
Senate roll call 127 · Individual votesPassed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 63 - 34. Record Vote Number: 127.(text as passed Senate: CR S4389-4390)
Senate roll call 127 · Individual votesConsidered by Senate. (consideration: CR S4319-4371, S4386-4391)
Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)
Star Print ordered on on the bill.
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 3.
Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Sponsor introductory remarks on measure. (CR S9-11)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Apr 7, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.5 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.5 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.5 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.5 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.